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Abstract
Background: Extremely preterm infants are at high risk of neonatal mortality and adverse outcome. Survival rates are slowly
improving, but increased survival may come at the expense of more handicaps.
Methodology/Principal Findings: Prospective population-based cohort study of all infants born at 23 to 27 weeks of
gestation in the Netherlands in 2007. 276 of 345 (80%) infants were born alive. Early neonatal death occurred in 96 (34.8%)
live born infants, including 61 cases of delivery room death. 29 (10.5%) infants died during the late neonatal period. Survival
rates for live born infants at 23, 24, 25 and 26 weeks of gestation were 0%, 6.7%, 57.9% and 71% respectively. 43.1% of 144
surviving infants developed severe neonatal morbidity (retinopathy of prematurity grade $3, bronchopulmonary dysplasia
and/or severe brain injury). At two years of age 70.6% of the children had no disability, 17.6% was mild disabled and 11.8%
had a moderate-to-severe disability. Severe brain injury (p = 0.028), retinopathy of prematurity grade $3 (p = 0.024), low
gestational age (p = 0.019) and non-Dutch nationality of the mother (p = 0.004) increased the risk of disability.
Conclusions/Significance: 52% of extremely preterm infants born in the Netherlands in 2007 survived. Surviving infants had
less severe neonatal morbidity compared to previous studies. At two years of age less than 30% of the infants were
disabled. Disability was associated with gestational age and neonatal morbidity.
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Introduction
Over the past years active treatment of extremely preterm
infants has been a major topic of discussion in the Netherlands,
fueled by a restrictive treatment policy of infants born at less than
25 weeks of gestation [1]. Neonatal mortality of extremely preterm
infants ,27 weeks of gestation ranges from 44 to 70% in Europe
[2,3]. With more infants surviving extreme preterm birth [4], data
on prevalence of neonatal morbidity may predict long-term
outcome [5,6]. Previous studies [5,7–12] reported rates of infants
surviving without serious morbidity at discharge from the neonatal
intensive care unit (NICU) ranging from 37 to 54% [8,11,12]. Few
studies have reported long-term mental and psychomotor impair-
ment in extremely preterm infants [6,13–19].
In case of imminent extreme preterm birth, counseling of the
parents about short and long-term outcome of the infant is pivotal,
but up to now, these data are not available for the Dutch
population. The PRospective Evaluation of perinatal management
of extremely PREterm infants (PrePre) study is a population-based
cohort study in the Netherlands on the outcome of extremely
preterm infants. All ten Dutch perinatal centers collected data on
every infant born at 23 to 27 weeks of gestation in 2007. At the
corrected age of two years survivors were seen for follow-up. The
objective of the PrePre-study was to evaluate neonatal mortality,
morbidity and long-term disabilities of infants born before
27 weeks of gestation in the Netherlands.
Methods
Study Population
The study population consisted of all infants born at gestational
ages of 23 0/7 to 26 6/7 weeks in the Netherlands in 2007. Both
stillborn and live born infants were included.
Data Collection
Selected data on maternal and child characteristics, pregnancy,
delivery, mortality, and neonatal morbidity from the Dutch
Neonatal Centers (Neoned) and the Netherlands Perinatal
Registry (NPR), and follow-up data at the corrected age of two
years from the Dutch Neonatal Follow-Up (LNF) Study Group
were analyzed anonymously.
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Follow-up at the corrected age of two years consisted of a
complete physical examination and testing of mental and
psychomotor development with the third edition of the Bayley
Scales of Infant and Toddler Development (BSID-III) [20]. Scores
were reported as Mental Development Index (MDI) and
Psychomotor Development Index (PDI), standardized with a
mean score of 100 and a standard deviation of 15 points. Cerebral
palsy was classified by the Gross Motor Function Classification
System (GFMCS) [21].
Dutch Healthcare System
In the Netherlands all citizens are obliged to purchase basic
health insurance, which coverers obstetric care. Early ultrasound
examination is done to confirm pregnancy and determine
gestational age at 8 to 12 postmenstrual weeks and at 20 weeks
of gestation a second ultrasound examination is performed to
screen for congenital anomalies and developmental problems.
The Dutch guideline on management of extremely preterm
infants advised active treatment at gestational ages $25 weeks and
comfort care for those ,24 weeks. Infants born at 24 weeks
received comfort care unless they appeared vital at birth [1]. In
cases of medical futility of treatment, care was withdrawn.
Definitions
Intrauterine fetal death was defined as no fetal heart action
before labor onset and intrapartum death as stillbirth of a fetus alive
at labor onset. Live birth was defined in accordance to the
guidelines of the World Health Organization (WHO) [22].
Ultrasound examination was used to determine gestational age,
when not available gestational age was calculated based on the first
day of the last menstruation. Infants with birth weight less than the
10th percentile for gestational age [23] were classified as small for
date.
Preterm premature rupture of membranes (PPROM) was
defined as membranes ruptured .24 hours before birth and
antenatal corticosteroid use as at least two doses of betamethasone
24 hours apart before delivery.
Bronchopulmonary dysplasia (BPD) was defined as oxygen
dependency at 36 postmenstrual weeks [24]. Necrotizing enteroco-
litis (NEC) was characterized by the presence of pneumatosis
intestinalis or bowel perforation. Retinopathy of prematurity (ROP)
was graded in accordance to the International Classification of
Retinopathy of Prematurity [25]. Intraventricular hemorrhage
(IVH) was staged according to Papile et al. [26] and cystic
periventricular leukomalacia (cPVL) according to De Vries et al.
[27]. Patent ductus arteriosus (PDA) was diagnosed when requiring
pharmacological or surgical treatment. Severe brain injury (SBI) was
defined as IVH grade $3 and/or cPVL. Severe morbidity was
defined as BPD and/or ROP grade$3 and/or severe brain injury.
Mild disability at follow-up was defined as at least one of the
following outcomes: cerebral palsy grade 1 and a MDI and/or
PDI of 70–84 points. Moderate-to-severe disability was defined as
at least one of the following: cerebral palsy grade 2–5, MDI and/
or PDI ,70, no useful hearing even with aids or more than 40dB
hearing loss with aids and blind, only perceiving light or sight
worse than 6/18 when corrected.
Statistical Analysis
Statistical analyses were performed with SPSS version 17 (IBM,
Armonk, NY). Odds ratios (ORs) and 95% confidence intervals
(CIs) were calculated by logistic regression analysis. Multivariate
logistic regression analysis included gestational age, birth weight
categories, gender, caesarean section, antenatal steroids and Dutch
nationality as independent factors. Groups were compared with x2
or Mann-Whitney test. P values ,0.05 were considered statisti-
cally significant.
Results
In 2007, 345 extremely preterm infants were born at 23 0/7 to
26 6/7 weeks of gestation out of 299 deliveries: 276 were born
alive, and 69 were stillborn and 44 (12.8%) infants were born due
to termination of pregnancy.
Maternal characteristics, obstetric interventions and child
characteristics, subdivided by gestational age and 250 grams birth
weight categories, are shown in Table 1. Mean age of the mothers
was 29.8 (range 17–44) years, 12 (3.5%) mothers were ,20 years
and 10 (2.9%) were 40 years or older. 234 mothers were ethnic
Dutch and Dutch nationality was associated with a higher birth
weight (p = 0.012). Caesarean sections were done in 78 deliveries
and the incidence increased with gestational age (OR 7.429; 95%
confidence interval (CI) 4.218–13.084; p,.001). Infants born by
caesarean section had a lower birth weight for gestational age (250
gram increase OR 0.397; 95% CI 0.257–0.613; p,.001) and were
more often small for date (p = 0.026 at 26 weeks of gestation).
The number of infants increased with advancing gestational age
(Table 1). Birth weight increased with every week of gestation
(p,.001). Girls weighed less than boys (p = 0.002). The incidence
of low Apgar scores (#3 at 5 minutes) was higher in more preterm
infants (p,.001) and in infants within a lower birth weight
category (p,.001).
Mortality rates are shown in Figure 1. 20.0% of the infants were
stillborn, ranging from 73.2% at 23 weeks of gestation to 6.9% at
26 weeks. 77.8% of infants with a birth weight ,500 g were
stillborn compared to 0% of infants with a birth weight more than
1000 g. 33 (47.8%) stillbirths were due to intrauterine fetal death.
Low birth weight (250 g increase OR 0.191; 95% CI 0.101–0.361;
p,.001), low gestational age (1 week increase OR 0.391; 95% CI
0.276–0.552; p,.001) and Dutch nationality of the mother (OR
2.266; 95% CI 1.074–4.783; p = 0.032) were associated with a
higher incidence of stillbirth in multivariate analysis.
61/276 (22.1%) live born infants died in the delivery room,
ranging from 100% at 23 weeks to 0.8% at 26 weeks of gestation.
In 75.4% of delivery room deaths a restrictive treatment policy (no
cardiac resuscitation, no intubation, no supplemental oxygen or no
resuscitation at all) was decided upon before birth: 100% at 23
weeks of gestation, 81.3% at 24 weeks, 38.5% at 25 weeks of
gestation, and 0% at 26 weeks of gestation (1 week increase OR
0.127; 95% CI 0.036–0.450; p,.001). In 8 (13%) cases of delivery
room death, the decision not to treat actively was based on specific
parental request. Live born infants who died in the delivery room
with a restrictive treatment policy pre-arranged before birth had a
lower gestational age than infants who died in delivery room
despite active treatment (p,.001). One infant (24 weeks of
gestation) survived despite a pre-arranged decision not to
resuscitate because no respiratory support was needed in the first
hours postpartum.
Neonatal intensive care was given to 215 (77.9%) live born
infants (Table 1). 96 (34.8%) live born infants died during the early
neonatal period (0–6 days postpartum), including 61 (63.5%) cases
of delivery room death. Early neonatal death was more common
in infants with a lower gestational age and birth weight in a lower
category (both p,.001). Late neonatal death (7–28 days postpar-
tum) occurred in 29 (10.5%) live born infants. In total, 132 (47.8%)
live born infants died before discharge from the hospital, with a
mortality rate of 95% of infants born at gestational ages ,25
weeks and a mortality rate of 35% at a gestational age of 25 or 26
weeks.
Outcome of Extremely Preterm Infants
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Mortality of live born infants was influenced by gestational age
(p,.001), birth weight (p,.001), gender (p = 0.014), caesarean
section (p = 0.022), and antenatal steroids (p = 0.008) (Table 2).
After correction for confounders only birth weight (p = 0.017) and
gender (p = 0.010) were of significant influence. Infants with birth
weight in a lower category and boys died more often than infants
within a higher birth weight category and girls, respectively.
Survival among infants of Dutch mothers (45.1%) and non-Dutch
Table 1. Characteristics of all births by gestational age (GA) and birth weight (BW).
% of infants by gestational age, weeks % of infants by birth weight, g
23 24 25 26 #500 501–750 751–1000 .1000 Total
n =56 n=55 n=104 n=130 n=36 n=153 n=117 n=39 n=345
Child characteristics
Female 41.1 38.2 51.0 45.4 63.9 48.4 40.2 30.8 45.2
Multiple 10.7 30.9 32.4 26.9 2.8 31.4 26.5 30.8 26.7
BW (g)/GA (weeks),
mean (SD)
545 (156) 656 (113) 768 (160) 851 (195) 24.1 (1.1) 25.0 (1.1) 25.8 (0.7) 26.4 (0.4) 745 (200)/25.3
(1.1)
Small for date (BW ,10th
percentile)
18.2 10.6 16.2 100 21.3 0 0 14.5
5 min Apgar #3,
#/live births (%)
80.0 66.7 16.8 7.4 75.0 38.3 12.8 2.6 24.3
NICU admission, #/live births
(%)
0 28.9 86.3 99.2 37.5 60.8 91.7 100 77.9
Obstetric factors
Caesarean section 0 1.8 12.5 49.2 8.3 25.5 18.8 35.9 22.6
Antenatal steroids, #/NICU
admissions (%)
0 7.7 41.5 49.2 66.7 43.8 36.0 61.5 43.7
PPROMa 10.7 27.3 25.0 20.8 8.3 24.2 22.2 20.5 21.4
Maternal characteristics
Dutch nationality 69.7 52.7 63.5 76.9 58.3 64.7 70.1 82.1 67.8
Age mother, mean (SD) 31.0 (5.9) 28.8 (6.1) 29.3 (5.2) 30.2 (5.5) 29.9 (6.2) 29.7 (5.9) 29.7 (5.0) 30.5 (5.7) 29.8 (5.6)
aPPROM: Preterm premature rupture of membranes.
doi:10.1371/journal.pone.0041302.t001
Figure 1. Mortality of all infants born (n=345) in the Netherlands between January 1, 2007 and December 31, 2007 by gestational
age (weeks) and birth weight (grams).
doi:10.1371/journal.pone.0041302.g001
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mothers (55.7%) was not significantly different. Use of antenatal
steroids increased the risk of severe morbidity in NICU survivors
(p = 0.016) (Table 2).
71/215 (33.0%) infants died during their NICU stay. Of these
infants 57.7% had SBI and/or NEC. None of them developed
BPD or ROP because of death before these diagnoses could be
established. Development of SBI and/or NEC was not influenced
by gestational age (p = 0.336) or birth weight (p = 0.209). Based on
the Dutch vision on management of extremely preterm infants we
expect that a decision was made to withdraw intensive care in
these infants who developed severe morbidity. Table 3 shows the
prevalence of neonatal morbidity in 144 infants discharged from
the hospital. 56.9% did not develop severe morbidity during their
stay in the NICU (including ROP grade $3, BPD and/or SBI)
and 11.1% developed two or more morbidities (including ROP
grade $3, NEC, BPD, IVH grade $3 and PVL). Table 4 shows
that ROP grade $3 (p = 0.047) and two or more morbidities
(p = 0.030) increased with decreasing gestational age, the incidence
of BPD increased with decreasing birth weight (p = 0.021). Infants
who died in the NICU had more often NEC (OR 2.902; 95% CI
1.277–6.596; p = 0.011), IVH grade $3 (OR 9.114; 95% CI
4.103–20.248; p,.001) and SBI (OR 3.197; 95% CI 1.719–5.946;
p,.001) than survivors. 136/144 (94.4%) survivors were seen for
follow-up at the corrected age of two years. 70.6% had no
disability, 17.6% had a mild disability and 11.8% had a moderate-
to-severe disability (Table 3). Mean MDI scores were 97 (SD 14.2)
and mean PDI scores were 95 (SD 14.3), not influenced by
gestational age or birth weight. The same held true for the severity
of disabilities, except for a significant association between
gestational age and moderate-to-severe disability (OR 0.149;
95% CI 0.032–0.679; p= 0.014).
Logistic regression analysis was done for associations between
neonatal morbidities during NICU stay and disability at two years
of age (Table 5). Children with IVH grade $3 (p= 0.006), SBI
(p = 0.028) and severe morbidity (p = 0.050) were diagnosed more
often with mild disability. ROP grade $3 (p= 0.024) and two or
more morbidities (p = 0.016) had more moderate-to-severe
disability. In univariate analysis only nationality of the mother
significantly influenced development of disability (p = 0.026). After
correction for confounding factors, an association was found
between gestational age (p = 0.019), caesarean section (p= 0.002)
and Dutch nationality of the mother (p = 0.004) and disability at
two years of age (Table 2). Children with a lower gestational age,
children born by caesarean section and children of non-Dutch
mothers developed more disability than other children.
Discussion
This study on outcome of extremely preterm infants in the
Netherlands showed a mortality rate of 47.8% among live born
infants. 56.9% of infants discharged from the hospital were free
from severe morbidity during their hospital stay. At the corrected
age of two years, disability was present in 29.4% of the children.
Gestational age influenced development of moderate-to-severe
disability but was not predictive for mild disability. An unexpected
finding was that infants of mothers treated with antenatal steroids
developed more severe neonatal morbidity.
Severe morbidity, mainly SBI, predicted development of mild
disability at two years of age and ROP grade $3 was predictive of
moderate-to-severe disability. Leversen et al. [6] reported an
association between SBI and ROP in the NICU and major
neurosensory disability at two years of age. Based on these findings
neonatal morbidities can be seen as predicting factors of disability
at two years of age.
Mortality rates of live born infants in population-based cohort
studies of extremely preterm infants in Western countries
[2,3,7,8,10,11] vary greatly. The mortality rate of live born
infants we found is comparable with other studies. Our mortality
rate of live born infants at a gestational age ,25 weeks was high
(95.0%) compared to similar studies [2,3,7,8,10,11]. This differ-
ence can be explained by the restrictive treatment policy of infants
born at gestational ages ,25 weeks in the Netherlands during the
study period [1].
56.9% of the infants discharged home did not develop severe
morbidity in the NICU in our study. The prevalence of BPD and
ROP grade $3 was 24.3% and 8.3%, respectively. Other studies
reported a markedly higher prevalence of these morbidities in
infants born at a gestational age $25 weeks. The prevalence of
BPD in other studies ranged from 38 [7] to 68% [5] and the
Table 2. Univariate and multivariate logistic regression analysis of mortality, severe morbidity and diability at two years of age.
Mortalitya Severe morbidityb Disabilityc
Univariate Multivariate Univariate Multivariate Univariate Multivariate
Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI)
Gestational
age
0.236 (0.15920.352)* 0.561 (0.29121.081) 0.746 (0.39521.412) 0.914 (0.39522.118) 0.574 (0.28221.171) 0.281 (0.09820.808)*
Birth weight 0.351 (0.24320.508)* 0.536 (0.32220.894)* 0.799 (0.50021.276) 0.724 (0.40621.292) 0.915 (0.54621.532) 1.331 (0.68722.579)
Genderd 1.825 (1.13022.948)* 2.311 (1.22024.375)* 1.432 (0.73822.780) 1.854 (0.87323.939) 1.069 (0.51122.239) 1.609 (0.66923.868)
Caesarean
section
0.532 (0.30920.914)* 1.354 (.061922.963) 1.201 (0.60222.398) 1.252 (0.52123.007) 1.890 (0.88424.043) 5.715 (1.899217.198)*
Antenatal
steroids
0.456 (0.25520.817)* 0.557 (0.29821.039) 2.162 (1.08724.303)* 2.429 (1.17725.013)* 1.167 (0.55122.471) 1.281 (0.54723.000)
Dutch
nationality
0.653 (0.39221.086) 0.909 (0.46521.777) 0.999 (0.47922.083) 0.934 (0.41622.094) 0.407 (0.18420.900)* 0.254 (0.09920.651)*
*p,0.05.
aMortality of the live born infants at discharge home.
bSevere morbidity in survivors to discharge.
cAny disability (mild and moderate-to-severe) at two years of age in children seen for follow-up.
dOdds ratio displays chance of boys compared to girls.
doi:10.1371/journal.pone.0041302.t002
Outcome of Extremely Preterm Infants
PLoS ONE | www.plosone.org 4 July 2012 | Volume 7 | Issue 7 | e41302
Table 3. Neonatal morbidity at discharge home and disability at two years of age by gestational age and birth weight.
% of infants by gestational age, weeks % of infants by birth weight, g
24 25 26 501–750 751–1000 .1000 Total
Neonatal morbidity
Infants discharged home n= 3 n = 55 n = 86 n = 44 n = 70 n = 30 n = 144
Retinopathy of prematurity, any grade 33.3 54.5 26.7 50.0 35.7 23.3 37.5
Retinopathy of prematurity, grade 3 or more 33.3 14.5 3.5 13.6 7.1 3.3 8.3
Bronchopulmonary dysplasia 33.3 29.1 20.9 40.9 14.3 23.3 24.3
Necrotizing enterocolitis 0 9.1 9.3 4.5 11.4 10.0 9.0
Intraventricular hemorrhage, any grade 0 23.6 14.0 9.1 24.3 13.3 17.4
Intraventricular hemorrhage, grade 3 or more 0 9.1 5.8 2.3 10.0 6.6 6.9
Cystic periventricular leukomalacia 0 18.2 12.8 9.1 17.1 16.7 14.6
Severe brain injurya 0 25.5 18.6 11.4 25.7 23.3 20.8
Patent ductus arteriosusb 100 50.9 50.0 54.5 47.1 56.7 51.4
2 or more morbiditiesc 33.3 18.2 5.8 11.4 11.4 10.0 11.1
Severe morbidityd 33.3 50.9 38.4 52.3 37.1 43.3 43.1
Disability at two years of age
Infants seen at follow-up n = 3 n = 53 n = 80 n = 44 n = 64 n = 28 n = 136
Mild disabilitye 33.3 18.9 16.3 22.7 17.2 10.7 17.6
Moderate-to-severe disabilityf 0 17.0 8.8 11.4 7.8 21.4 11.8
No disability 66.7 64.2 75.0 65.9 75.0 67.9 70.6
*p,0.05.
aIntraventricular hemorrhage grade 3 or more and/or cystic periventricular leukomalacia.
bSymptomatic patent ductus arteriosus which required treatment.
cIncluding: Retinopathy grade 3 or more, necrotizing enterocolitis, bronchopulmonary dysplasia, intraventricular hemorrhage grade 3 or more, cystic periventricular
leukomalacia.
dRetinopathy of prematurity grade 3 or more and/or bronchopulmonary dysplasia and/or severe brain injury.
eCerebral palsy grade 1 and/or MDI 70–84 and/or PDI 70–84.
fCerebral palsy grade 2–5, MDI and/or PDI ,70, deafness or more than 40 dB hearing loss with aids, blind or only perceiving light or sight worse than 6/18 when
corrected.
doi:10.1371/journal.pone.0041302.t003
Table 4. Logistic regression analysis of morbidities by gestational age, birth weight and multivariate.
Gestational age Birth weightˆ
Univariate Multivariatea Univariate Multivariatea
Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI)
Retinopathy of prematurity grade 3 or more 0.173 (0.05320.567)* 0.173 (0.03120.975)* 0.475 (0.19021.188) 0.972 (0.28723.298)
Necrotizing enterocolitis 1.181 (0.38623.609) 0.850 (0.21122.426) 1.460 (0.65323.264) 1.445 (0.57323.641)
Bronchopulmonary dysplasia 0.882 (0.42521.828) 1.011 (0.36522.801) 0.552 (0.31320.974)* 0.437 (0.21620.883)*
Intraventricular hemorrhage grade 3 or more 0.705 (0.21222.344) 1.000 (0.16725.981) 1.520 (0.61323.772) 1.452 (0.43524.847)
Cystic periventricular leukomalacia 0.816 (0.33921.965) 0.791 (0.24422.563) 1.398 (0.72822.687) 1.442 (0.64823.208)
Severe brain injuryb 0.768 (0.35821.651) 0.825 (0.28422.396) 1.509 (0.85222.672) 1.569 (0.75923.243)
Patent ductus arteriosusc 0.906 (0.48321.702) 0.938 (0.41922.101) 1.011 (0.63821.601) 0.870 (0.49921.516)
2 or more morbiditiesd 0.319 (0.11920.857)* 0.198 (0.04620.855)* 0.940 (0.45121.958) 1.556 (0.59424.078)
Severe morbiditye 0.746 (0.39521.412) 0.914 (0.39522.118) 0.799 (0.50021.276) 0.724 (0.40621.292)
*p,0.05.
ˆ Birth weight categories: #500 g, 501-750 g, 751-100 g, and .1000 g.
aIncluding: gestational age, birth weight, gender, cesarean section, antenatal steroids, Dutch nationality.
bIntraventricular hemorrhage grade 3 or more and/or cystic periventricular leukomalacia.
cSymptomatic patent ductus arteriosus which required treatment.
dIncluding: Retinopathy grade 3 or more, necrotizing enterocolitis, bronchopulmonary dysplasia, intraventricular hemorrhage grade 3 or more, cystic periventricular
leukomalacia.
eRetinopathy of prematurity grade 3 or more and/or bronchopulmonary dysplasia and/or severe brain injury.
doi:10.1371/journal.pone.0041302.t004
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prevalence of ROP grade $3 ranged from 9 [7] to 25.4% [5].
The prevalence of IVH grade $3 was 6.7% in our study and
lower than all but one other study [7].
A possible explanation for the low prevalence of these
morbidities in our study is the Dutch policy about futile medical
care; treatment will be stopped when it is no longer proportional to
the expected long-term quality of life. Withdrawal of intensive care
is more common in infants with IVH grade $3, ROP grade $3
and infants developing severe chronic lung disease.
Antenatal corticosteroid treatment may improve perinatal
health of preterm infants [28], although the benefit at gestational
ages less than 26 weeks is still uncertain [29]. In our study, more
severe morbidity, particularly SBI, was found in infants born of
mothers treated with antenatal steroids, even when corrected for
confounding factors. This was in contrast to other studies
reporting less IVH grade $3 in infants exposed to antenatal
steroids [30–32]. No other studies have detected an increase of
severe morbidity in infants born of mothers treated with antenatal
corticosteroids at gestational ages less than 28 weeks [28,29,31]. A
recent report from the NICHHD Neonatal Research Network in
the USA re-affirmed a positive association of antenatal cortico-
steroids with mortality and neurodevelopmental outcome among
infants born at 22 to 25 weeks of gestation [33]. This makes our
finding exceptional. The clinical implication of the increase in
severe morbidity remains unclear because the risk of disability at
two years of age in infants exposed to antenatal steroids was not
significantly increased.
At the corrected age of two years, 70.6% of the children had no
disability in this study. All but one [6] follow-up studies of
extremely preterm infants [6,13,14,18] reported more disability at
two to three years of age. Recent follow-up data at 18–22 months
of age from the NICHHD Neonatal Research Network in the
USA show rates of intact survival (defined as no death or
neurodevelopmental impairment by follow-up) of 44.3% at 25
weeks versus 32.7% in our study, but similar rates of no disability
in NICU survivors. Differences in the proportion of infants
disabled at two years of age can be explained by the different
definitions of disability used. Gestational age is not a good
predictor for long-term disability of extremely preterm infants,
based on our findings and international literature [6,13,14,18,19],
but it cannot be ruled out either.
The strengths of this study are the prospective population-based
design and the high response rate at follow-up. The design of the
study makes it comparable to other population-based cohort
studies of extremely preterm infants and provides information on
the international position of Dutch perinatal care.
One of the limitations of this study was inter-observer variation.
Questions on the study form could be interpreted differently, and
diagnosing and staging of neonatal morbidity and disability at two
years of age are also vulnerable to inter-observer variation.
Another problem was the selection of factors to be included in the
multivariate analysis. By selecting potential confounding factors we
possibly missed factors influencing our results. Furthermore, we
have to take into account the selection bias created by analyzing
morbidity and disability in survivors only.
The Dutch policy on management of extremely preterm infants
has been criticized because infants at gestational ages less than 25
weeks were not treated actively [34]. This policy was based on the
Hippocratic principle of ‘do no harm’ and quality of life [1]. A
recently published study on trends of care given in cases of
neonatal death in the United States of America reported a
significant increase in withdrawal and withholding of care over the
last ten years [35], explained by an increased recognition of
situations of futile medical care, which already is an important
factor in Dutch health care.
This study gives the first complete description of outcome of
extremely preterm infants born in the Netherlands in the 21th
century. To extrapolate the results of this study to other
populations, the Dutch organization of health care and policy
on treatment of extremely preterm infants must be taken into
account. Dutch health care is accessible for all citizens and is well
organized. Perinatal care is offered to almost all pregnant women
and termination of pregnancy is legalized. This organization of
health care possibly contributed to better maternal care and less
extremely preterm births.
In summary, almost half of the extremely preterm infants born
alive at 23 to 27 weeks of gestation in 2007 in the Netherlands
died. Infants surviving to discharge from the hospital had less
severe morbidity compared to other studies. At two years of age
Table 5. Logistic regression analysis of association between neonatal morbidity and disability at two years of age.
Mild disability Moderate-to-severe disability
Odds ratio (95% CI) Odds ratio (95% CI)
Retinopathy of prematurity grade 3 or more 1.635 (0.40826.553) 4.667 (1.222217.818)*
Necrotizing enterocolitis 0.498 (0.06024.124) 0.882 (0.09726.955)
Bronchopulmonary dysplasia 1.235 (0.46423.287) 2.556 (0.87327.484)
Intraventricular hemorrhage grade 3 or more 7.105 (1.748228.879)* 2.306 (0.436212.210)
Cystic periventricular leukomalacia 1.200 (0.36323.972) 0.810 (0.16923.868)
Severe brain injurya 2.937 (1.12227.689)* 0.877 (0.23223.317)
Patent ductus arteriosusb 0.733 (0.30321.776) 3.102 (0.947210.163)
2 or more morbiditiesc 1.667 (0.48825.698) 4.504 (1.322215.341)*
Severe morbidityd 2.481 (1.00026.159)* 1.308 (0.46023.716)
*p,0.05.
aIntraventricular hemorrhage grade 3 or more and/or cystic periventricular leukomalacia.
bSymptomatic patent ductus arteriosus which required treatment.
cIncluding: retinopathy grade 3 or more, necrotizing enterocolitis, bronchopulmonary dysplasia, intraventricular hemorrhage grade 3 or more, cystic periventricular
leukomalacia.
dRetinopathy of prematurity grade 3 or more and/or bronchopulmonary dysplasia and/or severe brain injury.
doi:10.1371/journal.pone.0041302.t005
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30% of the children were disabled and the risk of disability was
influenced by neonatal morbidity and gestational age. Questions
arose about the effect of antenatal steroid treatment on
development of neonatal morbidity and long-term disability, more
research on this topic is recommended to determine the safety of
this widely used treatment. The results of this study can be used in
counseling parents in case of imminent preterm birth and in
advising parents during their infant’s NICU stay.
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